Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prognostic test for early stage non small cell lung cancer (NSCLC)

Prognostic test for early stage non small cell lung cancer (NSCLC)

US Patent 8785131 · Granted Jul 22, 2014

Estimated economic value: $18,665,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Signaling conjugates and methods of use2024
Methods and probe combinations for detecting melanoma2022
Detection of chromosomal abnormalities associated with endometrial cancer2020
Signaling conjugates and methods of use2020
Double stranded linear nucleic acid probe2019
Detection of high grade dysplasia in cervical cells2019
Materials and methods for diagnosis, prognosis and assessment of therapeutic/pro2019
Method and compositions for detecting epidermal growth factor receptor variant f2019
Diagnostic methods for determining prognosis of non-small cell lung cancer2018
Signaling conjugates and methods of use2018
Diagnostic methods for determining prognosis of non-small cell lung cancer2018
Diagnostic methods for determining prognosis of non-small cell lung cancer2018